[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"app-context":3,"blog-disc-medicine-stock-is-down-22-after-fda-rejection-do-analysts-see-a-recovery-in-2026-FR":222},{"languages":4,"categories":41,"products":125,"competitors":149},[5,9,13,17,21,25,29,33,37],{"name":6,"code":7,"id":8},"English","EN","TGFuZ3VhZ2U6ZW4=",{"name":10,"code":11,"id":12},"Español","ES","TGFuZ3VhZ2U6ZXM=",{"name":14,"code":15,"id":16},"Português","PT","TGFuZ3VhZ2U6cHQ=",{"name":18,"code":19,"id":20},"日本語","JA","TGFuZ3VhZ2U6amE=",{"name":22,"code":23,"id":24},"한국어","KO","TGFuZ3VhZ2U6a28=",{"name":26,"code":27,"id":28},"Deutsch","DE","TGFuZ3VhZ2U6ZGU=",{"name":30,"code":31,"id":32},"Italiano","IT","TGFuZ3VhZ2U6aXQ=",{"name":34,"code":35,"id":36},"Français","FR","TGFuZ3VhZ2U6ZnI=",{"name":38,"code":39,"id":40},"中文 (中国)","ZH","TGFuZ3VhZ2U6emg=",[42,73,104],{"icon":43,"slug":44,"title":45,"description":46,"featuredLinks":47},"mingcute:stock-line","stock-market-basics","Stock Market Basics","\u003Cp>Beginners' guides and practical tips for understanding stock market investing.\u003C\u002Fp>\n",[48,53,58,63,68],{"url":49,"title":50,"description":51,"ogImage":52},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fwhat-makes-stocks-go-up-and-down","What Makes Stocks Go Up and Down | TIKR.com","Understanding what makes stock prices go up and down can help investors better navigate investing. Click to learn more!","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FWhat-makes-stocks-go-up-and-down-banner\u002FWhat-makes-stocks-go-up-and-down-banner.jpg?_i=AA",{"url":54,"title":55,"description":56,"ogImage":57},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fdividend-yield-meaning-formula-example","Dividend Yield: Meaning, Formula, Example | Tikr.com Blog | TIKR.com","The dividend yield is a key metric for investors looking to gauge the income potential of their investments. It measures how much a company pays out in","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FDividend-yield\u002FDividend-yield.png?_i=AA",{"url":59,"title":60,"description":61,"ogImage":62},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fmarket-capitalization-definition-formula-and-why-it-matters","Market Capitalization: Definition, Formula, and Why It Matters | TIKR.com","Long-term investors often look at various valuation metrics when deciding whether to invest in a particular company. One helpful metric to evaluate is","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FMarket-Capitalization-Definition-Formula-and-Why-It-Matters\u002FMarket-Capitalization-Definition-Formula-and-Why-It-Matters.png?_i=AA",{"url":64,"title":65,"description":66,"ogImage":67},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fearnings-per-share-definition-formula-and-why-eps-matters","Earnings Per Share: Definition, Formula, and Why EPS Matters | TIKR.com","Earnings Per Share (EPS) represents the portion of a company's net earnings allocated to each share. Click to learn more!","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FEPS-Defiinition-formula-and-why-EPS-matters-1\u002FEPS-Defiinition-formula-and-why-EPS-matters-1.png?_i=AA",{"url":69,"title":70,"description":71,"ogImage":72},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fwhat-is-a-stock-price-target","What Is a Stock Price Target? | TIKR.com","A price target is a stock's estimated future price. It can help investors quickly find undervalued stocks. Learn more now!","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FWhat-is-a-Stock-Price-Target-2\u002FWhat-is-a-Stock-Price-Target-2.png?_i=AA",{"icon":74,"slug":75,"title":76,"description":77,"featuredLinks":78},"material-symbols:analytics-outline","fundamental-analysis","Fundamental Analysis","\u003Cp>In-depth resources and financial metrics to help you evaluate companies like a pro.\u003C\u002Fp>\n",[79,84,89,94,99],{"url":80,"title":81,"description":82,"ogImage":83},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fshare-repurchase-why-do-companies-buy-back-their-stock","Share Repurchase: Why Do Companies Buy Back Their Stock? | TIKR.com","Share repurchases, or share buybacks, have gained popularity in the last two decades. According to a report from Goldman Sachs, stock buybacks initiated","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FTIKR-BLOG-COVER-PHOTOS-3_544a7f4e\u002FTIKR-BLOG-COVER-PHOTOS-3_544a7f4e.png?_i=AA",{"url":85,"title":86,"description":87,"ogImage":88},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fwhat-is-a-good-return-on-invested-capital","What Is a Good Return on Invested Capital? | TIKR.com","Learning about Return on Invested Capital (ROIC) can help investors spot highly profitable stocks that can drive long-term returns. Learn more now!","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FWhat-is-a-good-return-on-Invested-capital\u002FWhat-is-a-good-return-on-Invested-capital.png?_i=AA",{"url":90,"title":91,"description":92,"ogImage":93},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fwhat-is-a-good-return-on-equity-ratio","What is a Good Return on Equity Ratio | Tikr.com Blog | TIKR.com","Return on Equity (ROE) is a financial ratio that reflects a company's profitability in relation to the equity invested by shareholders. It basically","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FWhat-is-a-good-return-on-equity-ratio-1\u002FWhat-is-a-good-return-on-equity-ratio-1.jpg?_i=AA",{"url":95,"title":96,"description":97,"ogImage":98},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fwhat-is-a-good-p-e-ratio","What Is a Good P\u002FE Ratio? | TIKR.com","Financial analysts and investors look at various metrics before deciding whether a stock is a buy. One of the metrics is the price-to-earnings ratio (P\u002FE","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FWhat-is-a-good-PE-ratio-1\u002FWhat-is-a-good-PE-ratio-1.jpg?_i=AA",{"url":100,"title":101,"description":102,"ogImage":103},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Ftop-6-metrics-for-investing-in-reits","Top 6 Metrics for Investing in REITs | TIKR.com","Real estate has been one of the greatest asset classes for wealth creation in history, and investing in Real Estate Investment Trusts (REITs) can allow","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FGroup-10\u002FGroup-10.png?_i=AA",{"icon":105,"slug":106,"title":107,"description":108,"featuredLinks":109},"hugeicons:investigation","investing-lingo","Investing Lingo","\u003Cp>A comprehensive glossary of investing terms and jargon so you can speak the language of the markets confidently.\u003C\u002Fp>\n",[110,115,120],{"url":111,"title":112,"description":113,"ogImage":114},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fenterprise-value-definition-and-calculation","Enterprise Value: Definition and Calculation | Tikr.com Blog | TIKR.com","Enterprise value (EV) is a financial metric that offers a comprehensive snapshot of a company's total value. Unlike market capitalization which solely","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FEnterprise-Value-Definition-and-Calculation_37576e40\u002FEnterprise-Value-Definition-and-Calculation_37576e40.png?_i=AA",{"url":116,"title":117,"description":118,"ogImage":119},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Febitda-definition-formula-how-to-use-it","EBITDA: Definition, Formula, How to Use It | TIKR.com","EBITDA stands for earnings before interest, taxes, depreciation and amortization. It's a financial metric commonly used to evaluate a company's financial","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FEBITDA-Definition-Formula-How-to-Use-It\u002FEBITDA-Definition-Formula-How-to-Use-It.png?_i=AA",{"url":121,"title":122,"description":123,"ogImage":124},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fwhat-is-the-free-cash-flow-formula-and-why-does-it-matter","What is the Free Cash Flow Formula and Why Does It Matter | TIKR.com","Free cash flow, or FCF, is the cash a company generates after it accounts for outflows required to maintain business operations and support capital","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FWhat-is-the-free-cash-flow-formula\u002FWhat-is-the-free-cash-flow-formula.png?_i=AA",[126,130,134,137,141,145],{"slug":127,"modified":128,"title":129},"valuation-model-builder","2025-07-03T00:18:53","Value Stocks Quickly and Accurately",{"slug":131,"modified":132,"title":133},"stock-portfolio-tracking","2024-12-02T22:21:28","Monitor Your Portfolio",{"slug":75,"modified":135,"title":136},"2025-01-21T22:10:52","Instantly Analyze Companies with In-Depth Metrics",{"slug":138,"modified":139,"title":140},"stock-screener","2024-12-02T22:13:31","Find the Best Stocks to Buy",{"slug":142,"modified":143,"title":144},"investor-stock-portfolio","2025-01-21T22:02:56","Follow Investment Moves of Top Investors",{"slug":146,"modified":147,"title":148},"analyze-stocks","2025-07-23T16:04:24","Analyze Stocks",[150,154,158,162,166,170,174,178,182,186,190,194,198,202,206,210,214,218],{"slug":151,"title":152,"modified":153},"bloomberg","Bloomberg","2025-01-16T14:23:44",{"slug":155,"title":156,"modified":157},"morningstar","Morningstar","2025-01-16T14:25:16",{"slug":159,"title":160,"modified":161},"sentieo","Sentieo","2025-01-16T17:58:27",{"slug":163,"title":164,"modified":165},"googlefinance","Google Finance","2025-01-17T19:39:37",{"slug":167,"title":168,"modified":169},"tradingview","TradingView","2025-01-16T18:17:01",{"slug":171,"title":172,"modified":173},"factset","Factset","2025-01-16T18:20:16",{"slug":175,"title":176,"modified":177},"finviz","Finviz","2025-01-16T18:23:40",{"slug":179,"title":180,"modified":181},"ycharts","YCharts","2025-01-16T18:32:19",{"slug":183,"title":184,"modified":185},"marketbeat","MarketBeat","2025-03-11T00:27:23",{"slug":187,"title":188,"modified":189},"benzinga","Benzinga","2025-03-11T00:31:00",{"slug":191,"title":192,"modified":193},"gurufocus","Gurufocus","2025-03-11T00:31:12",{"slug":195,"title":196,"modified":197},"fast-graphs","FAST Graphs","2025-03-11T00:31:19",{"slug":199,"title":200,"modified":201},"tipranks","TipRanks","2025-03-11T00:31:26",{"slug":203,"title":204,"modified":205},"seeking-alpha","Seeking Alpha","2025-03-11T00:31:45",{"slug":207,"title":208,"modified":209},"thestreet","TheStreet","2025-03-11T00:31:52",{"slug":211,"title":212,"modified":213},"investing-com","Investing.com","2025-03-11T00:32:00",{"slug":215,"title":216,"modified":217},"zacks","Zacks","2025-03-26T15:40:40",{"slug":219,"title":220,"modified":221},"alphasense","AlphaSense","2025-03-11T00:32:15",{"post":223,"seo":259,"relatedPosts":266,"suggestedPosts":344},{"id":224,"title":225,"date":226,"modified":227,"excerpt":228,"content":229,"wordCount":230,"lang":231,"uri":232,"slug":233,"cloudinaryAssetId":234,"featuredImageOriginalUrl":235,"featuredImageMetadata":236,"author":239,"editor":245,"categories":250,"relatedPosts":256,"seo":257},92963,"L'action Disc Medicine a chuté de 22 % après le rejet de la FDA. Les analystes prévoient-ils une reprise en 2026 ?","2026-02-17T18:30:00","2026-02-17T17:57:01","\u003Cp>Les actions de Disc Medicine se sont effondrées après que la FDA a émis une \"Complete Response Letter\" pour la bitopertine, citant un manque de corrélation entre les données des biomarqueurs et les bénéfices cliniques. \u003C\u002Fp>\n","\n\u003Ch3 class=\"wp-block-heading\" id=\"h-k-ey-stats-for-disc-medicine-stock\">\u003Cstrong>Stats clés\u003C\u002Fstrong> pour l'\u003Cstrong> action Disc Medicine\u003C\u002Fstrong>\u003C\u002Fh3>\n\n\n\n\u003Cul class=\"wp-block-list\">\n\u003Cli>\u003Cstrong>Evolution récente :\u003C\u002Fstrong> -22%\u003C\u002Fli>\n\n\n\n\u003Cli>\u003Cstrong>Prix actuel :\u003C\u002Fstrong> ~56\u003C\u002Fli>\n\n\n\n\u003Cli>\u003Cstrong>Objectif du consensus de la rue :\u003C\u002Fstrong> ~120\u003C\u002Fli>\n\u003C\u002Ful>\n\n\n\n\u003Cp>\u003Cem>\u003Cstrong>\u003Cem>\u003Cstrong>\u003Cstrong>\u003Cem>\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fregister?ref=tikrblog\" target=\"_blank\" rel=\"noreferrer noopener\">Maintenant en ligne : Découvrez le potentiel de hausse de vos actions préférées en utilisant le nouveau modèle d'évaluation de TIKR (c'est gratuit).\u003C\u002Fa>\u003C\u002Fem>\u003C\u002Fstrong>\u003C\u002Fstrong>\u003C\u002Fem>\u003C\u002Fstrong>\u003C\u002Fem>\u003Cstrong>\u003Cem>\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fregister?ref=tikrblog\">&gt;&gt;&gt;\u003C\u002Fa>\u003C\u002Fem>\u003C\u002Fstrong>\u003C\u002Fp>\n\n\n\n\u003Ch2 class=\"wp-block-heading\" id=\"h-what-happened\">Qu'est-ce qui s'est passé ?\u003C\u002Fh2>\n\n\n\n\u003Cp>\u003Cstrong>Disc Medicine (\u003C\u002Fstrong>\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fstock\u002Fabout?cid=641326926&amp;tid=1806046282&amp;?ref=tikrblog\">\u003Cstrong>IRON\u003C\u002Fstrong>\u003C\u002Fa>\u003Cstrong>)\u003C\u002Fstrong> ont chuté de 21,9 % cette semaine, clôturant à 56,46 $, après que la société ait subi un revers réglementaire catastrophique.\u003C\u002Fp>\n\n\n\n\u003Cp>La FDA a émis une\u003Ca href=\"https:\u002F\u002Fwww.fiercebiotech.com\u002Fbiotech\u002Ffda-rejects-discs-rare-disease-drug-despite-commissioners-voucher\"> \"Complete Response Letter\" (CRL)\u003C\u002Fa>, essentiellement un rejet, pour son principal médicament candidat, la bitopertine, qui est conçu pour traiter une maladie rare de la peau appelée protoporphyrie érythropoïétique (PPE).\u003C\u002Fp>\n\n\n\n\u003Cp>Selon\u003Ca href=\"https:\u002F\u002Fwww.reuters.com\u002Fbusiness\u002Fhealthcare-pharmaceuticals\u002Fus-fda-declines-approve-disc-medicines-rare-disease-drug-2026-02-13\u002F\">les rapports\u003C\u002Fa>, la FDA a refusé d'approuver le médicament parce que les essais cliniques n'ont pas réussi à prouver un bénéfice tangible pour les patients, malgré l'amélioration des résultats de leurs tests sanguins (en particulier la réduction d'une toxine appelée protoporphyrine IX).\u003C\u002Fp>\n\n\n\n\u003Cp>Ce décalage entre les \"biomarqueurs\" et \"la façon dont les patients se sentent réellement\" est un piège classique de la biotechnologie.\u003C\u002Fp>\n\n\n\n\u003Cp>La nouvelle a fait l'effet d'un choc, car la direction s'était montrée incroyablement optimiste.\u003C\u002Fp>\n\n\n\n\u003Cp>Dans une présentation faite il y a quelques semaines, le PDG John Quisel a déclaré : \"Nous sommes sur le point d'obtenir l'approbation de notre programme principal... la date d'action prévue par la FDA n'est plus qu'une question de semaines\".\u003C\u002Fp>\n\n\n\n\u003Cp>Les investisseurs qui avaient cru à cette confiance ont été pris de court par le \"non\" catégorique de l'autorité de réglementation, qui obligera l'entreprise à mener un nouvel essai coûteux, retardant ainsi de plusieurs années les recettes potentielles.\u003C\u002Fp>\n\n\n\n\u003Cp>Malgré l'effondrement, certains analystes défendent l'action.\u003Ca href=\"https:\u002F\u002Fwww.investing.com\u002Fnews\u002Fanalyst-ratings\u002Fwedbush-initiates-coverage-on-zura-bio-stock-with-outperform-rating-93CH-4493430\"> Wedbush a réitéré sa notation \"Outperform\"\u003C\u002Fa>, arguant que la réaction du marché est exagérée compte tenu des autres atouts de la société.\u003C\u002Fp>\n\n\n\n\u003Cfigure class=\"wp-block-image size-full\">\u003Cimg width=\"742\" height=\"405\" data-public-id=\"images\u002FIRON-1_929990c3ac\u002FIRON-1_929990c3ac.png\" loading=\"lazy\" decoding=\"async\" src=\"https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_742,h_405,c_scale\u002Ff_webp,q_auto\u002Fv1771308869\u002Fimages\u002FIRON-1_929990c3ac\u002FIRON-1_929990c3ac.png?_i=AA\" alt=\"\" class=\"wp-post-92963 wp-image-92999\" data-format=\"webp\" data-transformations=\"f_webp,q_auto\" data-version=\"1771308869\" data-seo=\"1\" srcset=\"https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Ff_webp,q_auto\u002Fv1771308869\u002Fimages\u002FIRON-1_929990c3ac\u002FIRON-1_929990c3ac.png?_i=AA 742w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_300,h_164,c_scale\u002Ff_webp,q_auto\u002Fv1771308869\u002Fimages\u002FIRON-1_929990c3ac\u002FIRON-1_929990c3ac.png?_i=AA 300w\" sizes=\"auto, (max-width: 742px) 100vw, 742px\" \u002F>\u003Cfigcaption class=\"wp-element-caption\">Objectif de cours de l'action Disc Medicine\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fregister?ref=tikrblog\">(TIKR\u003C\u002Fa>)\u003C\u002Ffigcaption>\u003C\u002Ffigure>\n\n\n\n\u003Cp>\u003Cstrong>\u003Cem>\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fregister?ref=tikrblog\">Voir les prévisions de croissance et les objectifs de prix des analystes pour l'action Disc Medicine (C'est gratuit !) &gt;&gt;&gt;\u003C\u002Fa>\u003C\u002Fem>\u003C\u002Fstrong>\u003C\u002Fp>\n\n\n\n\u003Ch2 class=\"wp-block-heading\" id=\"h-is-disc-medicine-undervalued-today\">\u003Cstrong>L'action Disc Medicine est-elle sous-évaluée aujourd'hui ?\u003C\u002Fstrong>\u003C\u002Fh2>\n\n\n\n\u003Cp>Alors que le marché panique, les analystes de Wall Street maintiennent leur position. L'objectif du consensus de la rue est actuellement de 120 $, ce qui implique une hausse de 102 % par rapport aux niveaux actuels.\u003C\u002Fp>\n\n\n\n\u003Cp>L'argumentaire s'appuie sur l'énorme trésorerie de l'entreprise, qui la protège d'une insolvabilité immédiate. Dans la transcription, le PDG John Quisel a déclaré : \"Nous avons environ 791 millions de dollars dans les livres... ce qui nous donne une marge de manœuvre jusqu'en 2029.\"\u003C\u002Fp>\n\n\n\n\u003Cp>Ce coussin de 791 millions de dollars signifie que Disc Medicine peut se permettre de mener les nouveaux essais exigés par la FDA sans diluer immédiatement les actionnaires.\u003C\u002Fp>\n\n\n\n\u003Cp>En outre, le rejet de la bitopertine ne met pas fin au reste du pipeline.\u003C\u002Fp>\n\n\n\n\u003Cp>Le PDG a souligné que DISC-0974 représentait une opportunité potentielle de \"plus de 4 milliards de dollars\" dans l'anémie myélofibrosante.\u003C\u002Fp>\n\n\n\n\u003Cp>Les analystes estiment que la valeur de ce deuxième actif, combinée à la trésorerie, est bien supérieure à la capitalisation boursière actuelle d'environ 2,1 milliards de dollars.\u003C\u002Fp>\n\n\n\n\u003Cp>\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fregister?ref=tikrblog\">Lisez la transcription complète de Disc Medicine sur TIKR pour découvrir la promesse initiale du PDG &gt;&gt;&gt;\u003C\u002Fa>\u003C\u002Fp>\n\n\n\n\u003Ch3 class=\"wp-block-heading\">\u003Cstrong>Analyse approfondie de la valorisation\u003C\u002Fstrong>\u003C\u002Fh3>\n\n\n\n\u003Cp>Nous examinons le \u003Cstrong>consensus de la rue,\u003C\u002Fstrong> qui suggère que la liquidation est une réaction excessive massive.\u003C\u002Fp>\n\n\n\n\u003Cul class=\"wp-block-list\">\n\u003Cli>\u003Cstrong>Prix cible de la rue :\u003C\u002Fstrong> ~120\u003C\u002Fli>\n\n\n\n\u003Cli>\u003Cstrong>Prix actuel :\u003C\u002Fstrong> ~56\u003C\u002Fli>\n\n\n\n\u003Cli>\u003Cstrong>Hausse implicite :\u003C\u002Fstrong> 102\u003C\u002Fli>\n\u003C\u002Ful>\n\n\n\n\u003Cp>\u003Cstrong>La théorie du \"plancher de trésorerie\" :\u003C\u002Fstrong> L'action se négocie à ~56 $, comme si l'ensemble de son pipeline n'avait aucune valeur. Cependant, avec près de 21 $ par action en liquidités, le marché attribue très peu de valeur à la plate-forme de médicaments actuelle.\u003C\u002Fp>\n\n\n\n\u003Cp>\u003Cstrong>Optionnalité du pipeline :\u003C\u002Fstrong> Bien que la mise sur le marché de la bitopertine soit retardée jusqu'à la mi-2027, l'entreprise dispose d'autres options. Si des données positives émergent du programme DISC-0974 plus tard dans l'année, cela pourrait catalyser une reprise indépendante du rejet de la FDA, comblant ainsi l'écart vers le niveau de plus de 100 $.\u003C\u002Fp>\n\n\n\n\u003Cp>\u003Cstrong>Conclusion :\u003C\u002Fstrong> Une décote à fort enjeu. Avec une chute de 22% et un calendrier non respecté, Disc Medicine est un titre de combat. Mais pour les investisseurs qui font confiance au consensus des analystes de 120 $, le prix actuel offre une chance rare d'acheter une biotechnologie bien financée à moitié prix.\u003C\u002Fp>\n\n\n\n\u003Cp>\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fregister?ref=tikrblog\">Découvrez les actions que les investisseurs milliardaires achètent (et vendent) avec TIKR.\u003C\u002Fa>\u003Cstrong>\u003Cem>\u003Cstrong>\u003Cem>\u003Cstrong>\u003Cem>\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fregister?ref=tikrblog\" target=\"_blank\" rel=\"noreferrer noopener\">\u003Cstrong>e\" ?\u003C\u002Fstrong> \u003Cstrong>[Cliquez ici pour voir le modèle d'évaluation complet d'Intuitive Machines].\u003C\u002Fstrong>\u003C\u002Fa>\u003C\u002Fem>\u003C\u002Fstrong>\u003C\u002Fem>\u003C\u002Fstrong>\u003C\u002Fem>\u003C\u002Fstrong>\u003C\u002Fp>\n\n\n\n\u003Ch2 class=\"wp-block-heading\" id=\"h-how-much-upside-does-disc-medicine-stock-have-from-here\">Quelle est l'ampleur de la hausse de l'action Disc Medicine à partir de maintenant ?\u003C\u002Fh2>\n\n\n\n\u003Cp>Grâce au \u003Cstrong>nouveau modèle d'évaluation de\u003C\u002Fstrong> TIKR, vous pouvez estimer le prix potentiel d'une action en moins d'une minute.\u003C\u002Fp>\n\n\n\n\u003Cp>Il vous suffit d'entrer trois données simples :\u003C\u002Fp>\n\n\n\n\u003Col class=\"wp-block-list\">\n\u003Cli>\u003Cem>Croissance du chiffre d'affaires\u003C\u002Fem>\u003C\u002Fli>\n\n\n\n\u003Cli>\u003Cem>Marges d'exploitation\u003C\u002Fem>\u003C\u002Fli>\n\n\n\n\u003Cli>\u003Cem>Multiplicateur de prix de sortie\u003C\u002Fem>\u003C\u002Fli>\n\u003C\u002Fol>\n\n\n\n\u003Cp>Si vous n'êtes pas sûr de ce qu'il faut saisir, TIKR remplit automatiquement chaque entrée en utilisant les estimations consensuelles des analystes, ce qui vous donne un point de départ rapide et fiable.\u003C\u002Fp>\n\n\n\n\u003Cp>TIKR calcule ensuite le prix potentiel de l'action et le rendement total dans le cadre de \u003Cstrong>scénarios\u003C\u002Fstrong> \u003Cstrong>haussier, baissier et de base,\u003C\u002Fstrong> ce qui vous permet de voir rapidement si une action est \u003Cstrong>sous-évaluée ou surévaluée\u003C\u002Fstrong>.\u003C\u002Fp>\n\n\n\n\u003Cp>\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fregister?ref=tikrblog\">\u003C\u002Fa>\u003Cstrong>\u003Cem>\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fregister?ref=tikrblog\">\u003Cstrong>\u003Cem>Découvrez la valeur réelle d'une action en moins de 60 secondes (gratuit avec TIKR) &gt;&gt;&gt;\u003C\u002Fem>\u003C\u002Fstrong>\u003C\u002Fa>\u003C\u002Fem>\u003C\u002Fstrong>\u003C\u002Fp>\n\n\n\n\u003Ch2 class=\"wp-block-heading\" id=\"h-looking-for-new-opportunities\">À la recherche de nouvelles opportunités ?\u003C\u002Fh2>\n\n\n\n\u003Cul class=\"wp-block-list\">\n\u003Cli>Voyez quelles actions\u003Cstrong> \u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fregister?ref=tikrblog\">les investisseurs milliardaires achètent\u003C\u002Fa> \u003C\u002Fstrong>afin que vous puissiez suivre l'argent intelligent.\u003C\u002Fli>\n\n\n\n\u003Cli>\u003Cstrong>\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fregister?ref=tikrblog\">Analysez les actions en seulement 5 minutes\u003C\u002Fa>\u003C\u002Fstrong> grâce à la plateforme tout-en-un et facile à utiliser de TIKR.\u003C\u002Fli>\n\n\n\n\u003Cli>Plus vous renversez de pierres... plus vous découvrirez d'opportunités. \u003Cstrong>\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fregister?ref=tikrblog\">Recherchez plus de 100 000 actions mondiales, les titres des principaux investisseurs mondiaux, et plus encore avec TIKR.\u003C\u002Fa>\u003C\u002Fstrong>\u003C\u002Fli>\n\u003C\u002Ful>\n\n\n\n\u003Ch2 class=\"wp-block-heading\">\u003Cstrong>Avis de non-responsabilité :\u003C\u002Fstrong>\u003C\u002Fh2>\n\n\n\n\u003Cp>\u003Cem>Veuillez noter que les articles de TIKR ne sont pas destinés à servir de conseils financiers ou d'investissement de la part de TIKR ou de notre équipe de contenu, et qu'ils ne constituent pas non plus des recommandations d'achat ou de vente d'actions. Nous créons notre contenu en nous basant sur les données d'investissement de TIKR Terminal et sur les estimations des analystes. Notre analyse peut ne pas inclure des nouvelles récentes de l'entreprise ou des mises à jour importantes. TIKR n'a aucune position dans les actions mentionnées. Nous vous remercions de votre lecture et vous souhaitons de bons investissements !\u003C\u002Fem>\u003C\u002Fp>\n",832,"fr","\u002Fblog\u002Fdisc-medicine-stock-is-down-22-after-fda-rejection-do-analysts-see-a-recovery-in-2026","disc-medicine-stock-is-down-22-after-fda-rejection-do-analysts-see-a-recovery-in-2026","images\u002F9-7\u002F9-7","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1771306284\u002Fimages\u002F9-7\u002F9-7.png?_i=AA",{"altText":237,"imageCredit":238},"Disc Medicine Stock Is Down 22% After FDA Rejection. Do Analysts See a Recovery in 2026?","@Truecreatives from TrueCreatives via Canva",{"name":240,"slug":241,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":244},"Wiltone Asuncion","wiltonetikr","author","",[],{"name":246,"slug":247,"role":248,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":249},"Thomas Richmond","thomastikr","editor",[],[251],{"name":252,"slug":253,"uri":254,"description":243,"postsCount":255},"Investissement Général","general-investing","\u002Fblog\u002Fcategory\u002Fgeneral-investing",0,[],{"title":237,"metaDesc":258,"opengraphDescription":258,"twitterTitle":237,"twitterDescription":258},"Disc Medicine shares crashed after the FDA issued a &#8220;Complete Response Letter&#8221; for bitopertin, citing a lack of correlation between biomarker data and clinical benefit.",{"title":237,"description":260,"twitterTitle":237,"twitterDescription":260,"author":240,"articlePublisher":261,"articlePublishedTime":226,"articleModifiedTime":227,"twitterLabel1":262,"twitterData1":263,"ogTitle":237,"ogDescription":260,"ogUrl":232,"ogImage":235,"ogImageWidth":264,"ogImageHeight":265,"ogImageSecureUrl":235,"ogImageAlt":237,"twitterImage":235},"Disc Medicine shares crashed after the FDA issued a “Complete Response Letter” for bitopertin, citing a lack of correlation between biomarker data and clinical benefit.","TIKR.com","Temps de lecture estimé","6 minutes",1200,630,[267,284,299,314,329],{"id":255,"title":268,"date":269,"excerpt":270,"wordCount":271,"uri":272,"slug":273,"cloudinaryAssetId":274,"featuredImageOriginalUrl":275,"featuredImageMetadata":276,"author":277,"categories":281,"relatedPosts":283},"L'action Avantor a chuté de 50 % par rapport à ses plus hauts niveaux. Les analystes entrevoient une reprise en 2026","2026-02-16 22:50:00","Voici pourquoi l'action d'Avantor a fortement chuté alors que la baisse de la demande biopharmaceutique et le déstockage des clients continuent de peser sur les résultats.",564,"\u002Fblog\u002Favantor-stock-has-fallen-50-from-highs-analysts-see-a-path-to-recovery-in-2026","avantor-stock-has-fallen-50-from-highs-analysts-see-a-path-to-recovery-in-2026","images\u002FAVTR-stock\u002FAVTR-stock","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1770871456\u002Fimages\u002FAVTR-stock\u002FAVTR-stock.png?_i=AA",{"altText":268},{"name":278,"slug":279,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":280},"Rexielyn Diaz","rexietikr",[],[282],{"name":252,"slug":253,"uri":254,"description":243,"postsCount":255},[],{"id":255,"title":285,"date":286,"excerpt":287,"wordCount":288,"uri":289,"slug":290,"cloudinaryAssetId":291,"featuredImageOriginalUrl":292,"featuredImageMetadata":293,"author":294,"categories":296,"relatedPosts":298},"L'action Unity Software est en baisse de plus de 50 % par rapport à ses plus hauts niveaux. L'objectif de 43 $ des analystes peut-il être maintenu ?","2026-02-16 22:40:00","Voici pourquoi l'action d'Unity a baissé après une forte progression, alors que les attentes concernant la rentabilité et le risque d'exécution se sont réajustées.",582,"\u002Fblog\u002Funity-software-stock-is-down-more-than-50-from-highs-can-analysts-43-target-hold","unity-software-stock-is-down-more-than-50-from-highs-can-analysts-43-target-hold","images\u002FU-stock\u002FU-stock","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1770870100\u002Fimages\u002FU-stock\u002FU-stock.png?_i=AA",{"altText":285},{"name":278,"slug":279,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":295},[],[297],{"name":252,"slug":253,"uri":254,"description":243,"postsCount":255},[],{"id":255,"title":300,"date":301,"excerpt":302,"wordCount":303,"uri":304,"slug":305,"cloudinaryAssetId":306,"featuredImageOriginalUrl":307,"featuredImageMetadata":308,"author":309,"categories":311,"relatedPosts":313},"L'action Centrus Energy recule de 20% après les résultats. L'objectif de 294 $ des analystes peut-il être maintenu ?","2026-02-16 22:30:00","Voici pourquoi l'action Centrus Energy a reculé après la publication des résultats, les investisseurs ayant réévalué la rentabilité à court terme.",546,"\u002Fblog\u002Fcentrus-energy-stock-pulls-back-20-after-earnings-can-analysts-294-target-hold","centrus-energy-stock-pulls-back-20-after-earnings-can-analysts-294-target-hold","images\u002FLEU-stock\u002FLEU-stock","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1770869332\u002Fimages\u002FLEU-stock\u002FLEU-stock.png?_i=AA",{"altText":300},{"name":278,"slug":279,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":310},[],[312],{"name":252,"slug":253,"uri":254,"description":243,"postsCount":255},[],{"id":255,"title":315,"date":316,"excerpt":317,"wordCount":318,"uri":319,"slug":320,"cloudinaryAssetId":321,"featuredImageOriginalUrl":322,"featuredImageMetadata":323,"author":324,"categories":326,"relatedPosts":328},"L'action Astera Labs recule de 20% après une forte hausse. L'objectif de 202 $ des analystes peut-il être tenu ?","2026-02-16 22:20:00","Voici pourquoi l'action Astera Labs (ALAB) s'est repliée, les investisseurs ayant réévalué l'évaluation après une forte hausse des bénéfices.",684,"\u002Fblog\u002Fastera-labs-stock-pulls-back-by-20-after-a-strong-run-can-analysts-202-target-hold","astera-labs-stock-pulls-back-by-20-after-a-strong-run-can-analysts-202-target-hold","images\u002FALAB-stock\u002FALAB-stock","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1770868721\u002Fimages\u002FALAB-stock\u002FALAB-stock.png?_i=AA",{"altText":315},{"name":278,"slug":279,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":325},[],[327],{"name":252,"slug":253,"uri":254,"description":243,"postsCount":255},[],{"id":255,"title":330,"date":331,"excerpt":332,"wordCount":333,"uri":334,"slug":335,"cloudinaryAssetId":336,"featuredImageOriginalUrl":337,"featuredImageMetadata":338,"author":339,"categories":341,"relatedPosts":343},"L'action Lyft a baissé de 35 % au cours de l'année écoulée. Voici ce que le marché réévalue","2026-02-16 22:10:00","Voici pourquoi les actions de Lyft ont baissé après les résultats, même si la rentabilité s'est améliorée et que le flux de trésorerie a atteint un nouveau point d'inflexion.",720,"\u002Fblog\u002Flyft-stock-is-down-35-over-the-past-year-heres-what-the-market-is-repricing","lyft-stock-is-down-35-over-the-past-year-heres-what-the-market-is-repricing","images\u002FLYFT-stock_923870fbf8\u002FLYFT-stock_923870fbf8","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1770867595\u002Fimages\u002FLYFT-stock_923870fbf8\u002FLYFT-stock_923870fbf8.png?_i=AA",{"altText":330},{"name":278,"slug":279,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":340},[],[342],{"name":252,"slug":253,"uri":254,"description":243,"postsCount":255},[],[345,365,380,395,410,425,445,460,475,492,507,525,540,555],{"id":255,"title":346,"date":347,"excerpt":348,"wordCount":349,"uri":350,"slug":351,"cloudinaryAssetId":352,"featuredImageOriginalUrl":353,"featuredImageMetadata":354,"author":355,"categories":359,"relatedPosts":364},"Goodyear a chuté de 14 % cette semaine. Voici à combien pourrait s'élever l'action en 2026","2026-02-17 17:05:00","Goodyear a chuté de 14% cette semaine après que la direction ait annoncé un fort ralentissement au premier trimestre. Selon notre évaluation, l'action pourrait augmenter de 35 % si les marges se redressent et si les économies de coûts se concrétisent en 2026.",744,"\u002Fblog\u002Fgoodyear-fell-14-this-week-heres-how-much-the-stock-could-rise-in-2026","goodyear-fell-14-this-week-heres-how-much-the-stock-could-rise-in-2026","images\u002F@MemoryStockphoto-from-ภาพของMemorystockphoto-via-Canva\u002F@MemoryStockphoto-from-ภาพของMemorystockphoto-via-Canva","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1771344296\u002Fimages\u002F@MemoryStockphoto-from-ภาพของMemorystockphoto-via-Canva\u002F@MemoryStockphoto-from-ภาพของMemorystockphoto-via-Canva.png?_i=AA",{"altText":346},{"name":356,"slug":357,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":358},"Nikko Henson","nikkotikr",[],[360],{"name":361,"slug":362,"uri":363,"description":243,"postsCount":255},"Examens des Actions","reviews","\u002Fblog\u002Fcategory\u002Freviews",[],{"id":255,"title":366,"date":367,"excerpt":368,"wordCount":369,"uri":370,"slug":371,"cloudinaryAssetId":372,"featuredImageOriginalUrl":373,"featuredImageMetadata":374,"author":375,"categories":377,"relatedPosts":379},"CRH est en hausse de 9% au cours des 6 derniers mois. Voici où les actions pourraient aller en 2026","2026-02-17 16:05:00","L'action CRH a progressé d'environ 9 % au cours des six derniers mois, et notre analyse suggère que le titre pourrait être en hausse constante jusqu'en 2026. Voici pourquoi la demande d'infrastructures, la solidité des prix et l'allocation disciplinée des capitaux continuent de soutenir la configuration.",652,"\u002Fblog\u002Fcrh-is-up-9-in-the-last-6-months-heres-where-shares-could-go-in-2026","crh-is-up-9-in-the-last-6-months-heres-where-shares-could-go-in-2026","images\u002F@Lucia-Chirilas-Images-via-Canva\u002F@Lucia-Chirilas-Images-via-Canva","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1771341635\u002Fimages\u002F@Lucia-Chirilas-Images-via-Canva\u002F@Lucia-Chirilas-Images-via-Canva.png?_i=AA",{"altText":366},{"name":356,"slug":357,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":376},[],[378],{"name":361,"slug":362,"uri":363,"description":243,"postsCount":255},[],{"id":255,"title":381,"date":382,"excerpt":383,"wordCount":384,"uri":385,"slug":386,"cloudinaryAssetId":387,"featuredImageOriginalUrl":388,"featuredImageMetadata":389,"author":390,"categories":392,"relatedPosts":394},"Caterpillar a augmenté de 22 % au cours des 30 derniers jours. Voici de combien l'action pourrait s'élever en 2026","2026-02-17 15:45:00","Caterpillar a progressé de 22 % au cours des 30 derniers jours après avoir annoncé des bénéfices records et une augmentation de son carnet de commandes. Voici pourquoi l'accélération de la demande en matière de production d'énergie et la visibilité des commandes sur plusieurs années pourraient continuer à soutenir l'action jusqu'en 2026.",702,"\u002Fblog\u002Fcaterpillar-is-up-22-in-the-last-30-days-heres-how-much-the-stock-could-rise-in-2026","caterpillar-is-up-22-in-the-last-30-days-heres-how-much-the-stock-could-rise-in-2026","images\u002F@Dushlik-from-Getty-Images-via-Canva\u002F@Dushlik-from-Getty-Images-via-Canva","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1771339523\u002Fimages\u002F@Dushlik-from-Getty-Images-via-Canva\u002F@Dushlik-from-Getty-Images-via-Canva.png?_i=AA",{"altText":381},{"name":356,"slug":357,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":391},[],[393],{"name":361,"slug":362,"uri":363,"description":243,"postsCount":255},[],{"id":255,"title":396,"date":397,"excerpt":398,"wordCount":399,"uri":400,"slug":401,"cloudinaryAssetId":402,"featuredImageOriginalUrl":403,"featuredImageMetadata":404,"author":405,"categories":407,"relatedPosts":409},"Ford a augmenté de 23% au cours des 6 derniers mois. Voici où l'action pourrait aller en 2026","2026-02-17 15:05:00","L'action Ford a progressé d'environ 23 % au cours des six derniers mois, et notre analyse suggère que les actions pourraient générer une hausse supplémentaire de 23 % jusqu'en 2026 et au-delà. Voici pourquoi la croissance de Ford Pro, la solidité de la gamme de camions et la discipline en matière de coûts sont au cœur de cette configuration.",683,"\u002Fblog\u002Fford-rose-23-in-the-last-6-months-heres-where-the-stock-could-go-in-2026","ford-rose-23-in-the-last-6-months-heres-where-the-stock-could-go-in-2026","images\u002F@Nikko-Henson-Maliwat-with-AI-via-Canva\u002F@Nikko-Henson-Maliwat-with-AI-via-Canva","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1771337756\u002Fimages\u002F@Nikko-Henson-Maliwat-with-AI-via-Canva\u002F@Nikko-Henson-Maliwat-with-AI-via-Canva.png?_i=AA",{"altText":396},{"name":356,"slug":357,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":406},[],[408],{"name":361,"slug":362,"uri":363,"description":243,"postsCount":255},[],{"id":255,"title":411,"date":412,"excerpt":413,"wordCount":414,"uri":415,"slug":416,"cloudinaryAssetId":417,"featuredImageOriginalUrl":418,"featuredImageMetadata":419,"author":420,"categories":422,"relatedPosts":424},"Occidental Petroleum a augmenté de 6 % au cours des 30 derniers jours. Voici à combien pourrait s'élever l'action en 2026","2026-02-17 14:35:00","Occidental Petroleum a augmenté d'environ 6 % au cours des 30 derniers jours, et notre analyse suggère que le titre pourrait offrir une hausse modérée jusqu'en 2026. Voici pourquoi l'exécution dans le Permien et l'allocation disciplinée des capitaux continuent de soutenir la configuration.",662,"\u002Fblog\u002Foccidental-petroleum-rose-6-in-the-last-30-days-heres-how-much-the-stock-could-rise-in-2026","occidental-petroleum-rose-6-in-the-last-30-days-heres-how-much-the-stock-could-rise-in-2026","images\u002F@Totojang-from-Getty-Images-Pro-via-Canva\u002F@Totojang-from-Getty-Images-Pro-via-Canva","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1771335736\u002Fimages\u002F@Totojang-from-Getty-Images-Pro-via-Canva\u002F@Totojang-from-Getty-Images-Pro-via-Canva.png?_i=AA",{"altText":411},{"name":356,"slug":357,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":421},[],[423],{"name":361,"slug":362,"uri":363,"description":243,"postsCount":255},[],{"id":255,"title":426,"date":427,"excerpt":428,"wordCount":429,"uri":430,"slug":431,"cloudinaryAssetId":432,"featuredImageOriginalUrl":433,"featuredImageMetadata":434,"author":435,"categories":439,"relatedPosts":444},"L'action de Las Vegas Sands a augmenté de 35 % l'an dernier : Voici où les actions pourraient aller en 2026","2026-02-17 17:00:00","L'action Las Vegas Sands pourrait offrir une hausse de 31 %, Patrick Dumont ayant remplacé Robert Goldstein en tant que président-directeur général à compter du 1er mars 2026. Il a hérité d'un EBITDA record de 806 millions de dollars pour Marina Bay Sands et d'un EBITDA raté de 608 millions de dollars pour Macao au quatrième trimestre, alors que l'objectif était de 700 millions de dollars.",2084,"\u002Fblog\u002Flas-vegas-sands-stock-rose-35-last-year-heres-where-shares-could-go-in-2026","las-vegas-sands-stock-rose-35-last-year-heres-where-shares-could-go-in-2026","images\u002FFEATURED-IMAGE-MAKER-238\u002FFEATURED-IMAGE-MAKER-238","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_360,c_scale\u002Ff_webp,q_auto\u002Fv1771317025\u002Fimages\u002FFEATURED-IMAGE-MAKER-238\u002FFEATURED-IMAGE-MAKER-238.png?_i=AA",{"altText":426},{"name":436,"slug":437,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":438},"Gian Estrada","giantikr",[],[440],{"name":441,"slug":442,"uri":443,"description":243,"postsCount":255},"Évaluation","valuation","\u002Fblog\u002Fcategory\u002Fvaluation",[],{"id":255,"title":446,"date":447,"excerpt":448,"wordCount":449,"uri":450,"slug":451,"cloudinaryAssetId":452,"featuredImageOriginalUrl":453,"featuredImageMetadata":454,"author":455,"categories":457,"relatedPosts":459},"Hershey bat les résultats du quatrième trimestre avec un chiffre d'affaires de 3 milliards de dollars : Ce qu'un objectif de 278 $ signifie pour les investisseurs","2026-02-17 13:00:00","Hershey (HSY), avec une hausse de 25 % par rapport à un objectif de 278 $, pourrait voir sa position confortée après la publication en février dernier d'un bénéfice supérieur à celui du quatrième trimestre et d'une hausse des prix de 10 % qui se répercute maintenant sur le compte de résultat avant la journée des investisseurs du 31 mars.",1748,"\u002Fblog\u002Fhershey-beats-q4-earnings-with-3-billion-in-revenue-what-a-278-target-means-for-investors","hershey-beats-q4-earnings-with-3-billion-in-revenue-what-a-278-target-means-for-investors","images\u002FFEATURED-IMAGE-MAKER-234\u002FFEATURED-IMAGE-MAKER-234","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_360,c_scale\u002Ff_webp,q_auto\u002Fv1771300753\u002Fimages\u002FFEATURED-IMAGE-MAKER-234\u002FFEATURED-IMAGE-MAKER-234.png?_i=AA",{"altText":446},{"name":436,"slug":437,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":456},[],[458],{"name":441,"slug":442,"uri":443,"description":243,"postsCount":255},[],{"id":255,"title":461,"date":462,"excerpt":463,"wordCount":464,"uri":465,"slug":466,"cloudinaryAssetId":467,"featuredImageOriginalUrl":468,"featuredImageMetadata":469,"author":470,"categories":472,"relatedPosts":474},"L'action Corteva se négocie près de ses plus hauts niveaux historiques, voici pourquoi elle peut atteindre de nouveaux sommets en 2026","2026-02-17 12:00:00","Corteva (CTVA), avec une hausse de 25 % par rapport à un objectif de 93 $, pourrait voir son dossier matériellement soutenu après une résolution de 610 millions de dollars de Bayer en février dernier, qui a accéléré de 5 ans l'octroi de licences pour les traits de maïs et ouvert pour la première fois le marché des licences pour le coton aux États-Unis.",1766,"\u002Fblog\u002Fcorteva-stock-trading-near-all-time-highs-heres-why-it-can-soar-new-highs-in-2026","corteva-stock-trading-near-all-time-highs-heres-why-it-can-soar-new-highs-in-2026","images\u002FFEATURED-IMAGE-MAKER-233\u002FFEATURED-IMAGE-MAKER-233","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_360,c_scale\u002Ff_webp,q_auto\u002Fv1771299016\u002Fimages\u002FFEATURED-IMAGE-MAKER-233\u002FFEATURED-IMAGE-MAKER-233.png?_i=AA",{"altText":461},{"name":436,"slug":437,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":471},[],[473],{"name":441,"slug":442,"uri":443,"description":243,"postsCount":255},[],{"id":255,"title":476,"date":477,"excerpt":478,"wordCount":479,"uri":480,"slug":481,"cloudinaryAssetId":482,"featuredImageOriginalUrl":483,"featuredImageMetadata":484,"author":485,"categories":489,"relatedPosts":491},"En baisse de 33 % au cours des 12 derniers mois, l'action Workiva peut-elle se redresser en 2026 ?","2026-02-17 11:04:00","L'action Workiva en baisse de 33 % en 12 mois. La plateforme de reporting d'entreprise peut-elle offrir un rendement de 39% d'ici 2027 ? Analyse des moteurs de croissance et des valorisations à venir.",1352,"\u002Fblog\u002Fdown-33-in-last-12-months-can-workiva-nyse-stock-deliver-better-results-in-2026","down-33-in-last-12-months-can-workiva-nyse-stock-deliver-better-results-in-2026","images\u002FWK-stock\u002FWK-stock","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1771223160\u002Fimages\u002FWK-stock\u002FWK-stock.png?_i=AA",{"altText":476},{"name":486,"slug":487,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":488},"Aditya Raghunath","adityatikr",[],[490],{"name":441,"slug":442,"uri":443,"description":243,"postsCount":255},[],{"id":255,"title":493,"date":494,"excerpt":495,"wordCount":496,"uri":497,"slug":498,"cloudinaryAssetId":499,"featuredImageOriginalUrl":500,"featuredImageMetadata":501,"author":502,"categories":504,"relatedPosts":506},"En baisse de 26% sur les 12 derniers mois, l'action Qualys peut-elle fournir de meilleurs résultats en 2026 ?","2026-02-17 10:10:00","L'action Qualys vise 126 $ d'ici 2028 grâce à la gestion des risques alimentée par l'IA. Analyse du potentiel de hausse de 20 %, de la croissance de la plateforme ETM et des rendements annuels de 7 % à venir.",1403,"\u002Fblog\u002Fdown-26-in-last-12-months-can-qualys-nasdaq-qlys-stock-deliver-better-results-in-2026","down-26-in-last-12-months-can-qualys-nasdaq-qlys-stock-deliver-better-results-in-2026","images\u002FQLYS-stock\u002FQLYS-stock","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1771148791\u002Fimages\u002FQLYS-stock\u002FQLYS-stock.png?_i=AA",{"altText":493},{"name":486,"slug":487,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":503},[],[505],{"name":441,"slug":442,"uri":443,"description":243,"postsCount":255},[],{"id":255,"title":508,"date":509,"excerpt":510,"wordCount":511,"uri":512,"slug":513,"cloudinaryAssetId":514,"featuredImageOriginalUrl":515,"featuredImageMetadata":516,"author":517,"categories":519,"relatedPosts":524},"L'action d'Applied Materials bondit de 8 % après la publication d'un bénéfice supérieur à celui du premier trimestre et de solides perspectives pour le deuxième trimestre","2026-02-16 21:20:00","Voici pourquoi l'action Applied Materials a bondi après avoir dépassé les estimations pour le premier trimestre et publié des prévisions supérieures aux attentes.",727,"\u002Fblog\u002Fapplied-materials-stock-jumps-8-after-q1-earnings-beat-and-strong-q2-outlook","applied-materials-stock-jumps-8-after-q1-earnings-beat-and-strong-q2-outlook","images\u002FAMAT-stock_9277752dc5\u002FAMAT-stock_9277752dc5","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1771186772\u002Fimages\u002FAMAT-stock_9277752dc5\u002FAMAT-stock_9277752dc5.png?_i=AA",{"altText":508},{"name":278,"slug":279,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":518},[],[520],{"name":521,"slug":522,"uri":523,"description":243,"postsCount":255},"Mises à Jour des Résultats","earnings-updates","\u002Fblog\u002Fcategory\u002Fearnings-updates",[],{"id":255,"title":526,"date":527,"excerpt":528,"wordCount":529,"uri":530,"slug":531,"cloudinaryAssetId":532,"featuredImageOriginalUrl":533,"featuredImageMetadata":534,"author":535,"categories":537,"relatedPosts":539},"Coinbase s'envole de 16 % après la publication d'un mauvais résultat au quatrième trimestre, la solidité de son bilan rassurant les investisseurs","2026-02-16 21:10:00","Voici pourquoi l'action Coinbase a bondi de 16 % après la publication des résultats, bien qu'elle ait manqué les estimations et annoncé une perte trimestrielle.",711,"\u002Fblog\u002Fcoinbase-rallies-16-after-q4-earnings-miss-as-balance-sheet-strength-reassures-investors","coinbase-rallies-16-after-q4-earnings-miss-as-balance-sheet-strength-reassures-investors","images\u002FCOIN-stock-1\u002FCOIN-stock-1","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1771124048\u002Fimages\u002FCOIN-stock-1\u002FCOIN-stock-1.png?_i=AA",{"altText":526},{"name":278,"slug":279,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":536},[],[538],{"name":521,"slug":522,"uri":523,"description":243,"postsCount":255},[],{"id":255,"title":541,"date":542,"excerpt":543,"wordCount":544,"uri":545,"slug":546,"cloudinaryAssetId":547,"featuredImageOriginalUrl":548,"featuredImageMetadata":549,"author":550,"categories":552,"relatedPosts":554},"L'action Crocs perd 1,6 % après les résultats du quatrième trimestre, la pression sur les marges pesant sur les actions","2026-02-16 21:00:00","Voici pourquoi l'action Crocs a glissé après les résultats du quatrième trimestre, la pression sur les marges ayant éclipsé un chiffre d'affaires et un bénéfice par action nettement supérieurs aux attentes.",660,"\u002Fblog\u002Fcrocs-stock-slips-1-6-after-q4-earnings-as-margin-pressure-weighs-on-shares","crocs-stock-slips-1-6-after-q4-earnings-as-margin-pressure-weighs-on-shares","images\u002FCROX-stock-1\u002FCROX-stock-1","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1771120594\u002Fimages\u002FCROX-stock-1\u002FCROX-stock-1.png?_i=AA",{"altText":541},{"name":278,"slug":279,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":551},[],[553],{"name":521,"slug":522,"uri":523,"description":243,"postsCount":255},[],{"id":255,"title":556,"date":557,"excerpt":558,"wordCount":559,"uri":560,"slug":561,"cloudinaryAssetId":562,"featuredImageOriginalUrl":563,"featuredImageMetadata":564,"author":565,"categories":567,"relatedPosts":569},"L'action CGNX a grimpé de 36 % après les résultats du quatrième trimestre. Voici pourquoi cela a changé la donne","2026-02-16 20:20:00","Voici pourquoi l'action de Cognex a bondi de 36 % en 2026 après que les bénéfices du quatrième trimestre aient mis en évidence une forte amélioration des marges malgré les objectifs de prix conservateurs des analystes.",736,"\u002Fblog\u002Fcgnx-stock-has-rallied-36-after-q4-earnings-heres-why-this-changed-the-narrative","cgnx-stock-has-rallied-36-after-q4-earnings-heres-why-this-changed-the-narrative","images\u002FCGNX-stock\u002FCGNX-stock","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1771017165\u002Fimages\u002FCGNX-stock\u002FCGNX-stock.png?_i=AA",{"altText":556},{"name":278,"slug":279,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":566},[],[568],{"name":521,"slug":522,"uri":523,"description":243,"postsCount":255},[]]